AbbVie to Present New Analyses from Pivotal Phase 3 Studies for RINVOQ(TM) (upadacitinib) in Atopic Dermatitis
AbbVie to Present New Analyses from Pivotal Phase 3 Studies for RINVOQ(TM) (upadacitinib) in Atopic Dermatitis |!| Mount Carmel
More from Southern Illinois
FOX News on Illinois
Wealthy elites bankroll Dem Senate candidate who has repeatedly touted 'grassroots' campaign
Southern Illinois
•
Mar 4, 2026
Southern Illinois University Carbondale
Former Barrington Village President Darch receives 2025 Simon-Edgar Award
Southern Illinois
•
Aug 6, 2025
Southern Illinois University Carbondale
SIU Carbondale again earns national honors for assisting transfer students
Southern Illinois
•
Aug 6, 2025
Southern Illinois University Carbondale
Businesses, students and alumni welcome at SIU's Fall Job and Internship Fair
Southern Illinois
•
Aug 6, 2025
East Central Reporter
Clay County Hospital names Samantha Deain August Employee of the Month
Southern Illinois
•
Aug 6, 2025
Mount Carmel Register
'Not backing down': activists block hydro plants in N.Macedonia
Southern Illinois
•
Aug 6, 2025
Mount Carmel Register
Steeper US tariffs take effect on many Brazilian goods
Southern Illinois
•
Aug 6, 2025
Mount Carmel Register
Bangladesh mystic singers face Islamist backlash
Southern Illinois
•
Aug 6, 2025